" class="no-js "lang="en-US"> Artificial Intelligence Archives - Page 8 of 16 - Medtech Alert
Friday, October 03, 2025

Sort by:

Date

Top Post

Viome Life Sciences Unveils CancerDetect™, the Future of Oral and Throat Cancer Detection

Viome Life Sciences, a mission-driven biotechnology company, announces the arrival of its CancerDetect™ test for oral […]

ETNA™ Device From the Leading Digital Health & AI Company Innodem Neurosciences Receives FDA"Breakthrough" Designation for Multiple Sclerosis

Innodem Neurosciences, a leading provider of innovation and technology for the convergence of neurosciences, digital […]

PharmEnable Announces Multi-target Collaboration With Denali Therapeutics in Neurodegenerative Disease

PharmEnable, an AI drug-discovery company mapping unexplored chemical space to deliver innovative medicines, has announced […]

Medical Microinstruments Launches New Simulator for Robotic Microsurgery

Medical Microinstruments (MMI) SpA, a robotics company dedicated to improving clinical outcomes for patients undergoing […]

Invenio Imaging Receives CE Mark to Detect Cancer at the Time of Surgery using Artificial Intelligence

Invenio Imaging, the leader in intraoperative fresh tissue imaging, announced today the CE Mark for […]

New Research Finds Computer Assisted Colonoscopy Identify More Precancerous Polyps Compared to Traditional Colonoscopy

Colonoscopies performed with computer-aided detection, or artificial intelligence, (AI) saw an increase in the overall […]

Leia Inc. Partners With Anatomage to Enable 3D Stereoscopic Learning Through Anatomage VR

Leia Inc., the leading 3D experience platform leveraging proprietary Nanotechnology and AI to democratize the […]

PostEra Spearheads AI-driven Drug Discovery Collaboration to Develop Antiviral Therapeutics With Initial $68m in NIH Funding

PostEra, a biotechnology company specializing in machine learning for preclinical drug discovery, today announced a […]

BenevolentAI Achieves Third Milestone in Its AI-enabled Drug Discovery Collaboration With AstraZeneca

BenevolentAI (Euronext Amsterdam: BAI), a leading clinical-stage AI-enabled drug discovery company, today announces that AstraZeneca […]

Strong Demand for Lung Intelligence Accelerates VIDA's Growth

VIDA Diagnostics, Inc. (VIDA), the leader in lung and respiratory intelligence, announced it has secured […]

Overjet Partners with Dental Care Alliance, Providing AI to Improve Patient Outcomes

Overjet, a leader in dental artificial intelligence solutions for providers and payers, today announced a […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more